Using nitrous acid-modified de Man, Rogosa, and Sharpe medium to selectively isolate and culture lactic acid bacteria from dairy foods by Renschler, Matthew A., Wyatt, Asia, Anene, Nnamdi, Robinson-Hill, Rona, Pickerill, Ethan S., Fox, Nathaniel E., Griffith, Julie A., McKillip, John L.

Get full text

Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling by Dowless, Michele, Lowery, Caitlin D., Shackleford, Terry, Renschler, Matthew, Stephens, Jennifer, Flack, Robert, Blosser, Wayne, Gupta, Simone, Stewart, Julie, Webster, Yue, Dempsey, Jack, VanWye, Alle B., Ebert, Philip, Iversen, Philip, Olsen, Jonathan B., Gong, Xueqian, Buchanan, Sean, Houghton, Peter, Stancato, Louis

Get full text

Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models by Lowery, Caitlin D, Dowless, Michele, Renschler, Matthew, Blosser, Wayne, VanWye, Alle B, Stephens, Jennifer R, Iversen, Philip W, Lin, Aimee Bence, Beckmann, Richard P, Krytska, Kateryna, Cole, Kristina A, Maris, John M, Hawkins, Douglas S, Rubin, Brian P, Kurmasheva, Raushan T, Houghton, Peter J, Gorlick, Richard, Kolb, E Anders, Kang, Min H, Reynolds, C Patrick, Erickson, Stephen W, Teicher, Beverly A, Smith, Malcolm A, Stancato, Louis F

Get full text

Pharmacogenomics, concepts for the future of perioperative medicine and pain management: A review by Kaye, Alan D., Koress, Cody M., Novitch, Matthew B., Jung, Jai Won, Urits, Ivan, Viswanath, Omar, Renschler, Jordan S., Alpaugh, Edward S., Cornett, Elyse M.

Get full text

Abstract A42: Prexasertib (LY2606368) is highly active as a monotherapy or in combination with chemotherapy in preclinical models of pediatric bone and soft tissue sarcoma by Lowery, Caitlin D., Blosser, Wayne, Dowless, Michele, Renschler, Matthew, Stephens, Jennifer, Beckmann, Richard, Stancato, Louis

Get full text

Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy by Lowery, Caitlin D., Blosser, Wayne, Dowless, Michele, Renschler, Matthew, Perez, Lisa V., Stephens, Jennifer, Pytowski, Bronislaw, Wasserstrom, Heather, Stancato, Louis F., Falcon, Beverly

Get full text

Abstract B43: The CDK4 and 6 inhibitor abemaciclib induces both epigenetic and immunogenic responses in preclinical models of Ewing’s sarcoma by Dowless, Michele, Lowery, Caitlin, Renschler, Matthew, Blosser, Wayne, Stephens, Jennifer, Flack, Robert, Credille, Kelly, Chen, Mia, Dorsey, Frank, Sams, Lillian, Ebert, Philip, Olsen, Jonathan, Shackleford, Terry, Houghton, Peter, Stancato, Louis

Get full text

Abemaciclib is Active in Preclinical Models of Ewing's Sarcoma via Multi-pronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling by Dowless, Michele S, Lowery, Caitlin D, Shackleford, Terry J, Renschler, Matthew, Stephens, Jennifer R, Flack, Robert, Blosser, Wayne, Gupta, Simone, Stewart, Julie, Webster, Yue, Dempsey, Jack, VanWye, Alle B, Ebert, Philip J, Iversen, Philip, Olsen, Jonathan B, Gong, Xueqian, Buchanan, Sean G, Houghton, Peter J, Stancato, Louis F

Get full text